Domestic pharmaceutical firms eyeing the items with sales greater than 10 billion won

Published: 2003-01-30 07:00:00

Updated: 2003-01-30 07:00:00

According to the overall management strategies of major domestic pharmaceutical firms this year, the majority of pharmaceutical firms are concentrating their sales and marketing efforts to cultivate ethicals with more than a 10 billion won in sales instead of heavily depending on the launching of...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK